AGC Biologics announced the appointment of Kasper Møller to the role of Chief Technical Officer. Møller will report to Patricio Massera, Chief Executive Officer.
Møller joined AGC Biologics in 2006 as a Scientist at the Copenhagen facility and has held the positions of Principal Scientist (2007) and Department Manager (2008) within Process Development. Beginning in 2010, Kasper led the Upstream Process Development teams and in 2011, he led process characterization and validation activities. In 2013 - 2014, Kasper was appointed Vice President of Process Development and in 2014 – 2017, Kasper was appointed Vice President of Manufacturing. Møller has most recently served as the site head for AGC Biologics' Copenhagen facility and his role was expanded to include oversight of the Heidelberg, Germany site as well as Global Supply Chain Management and Global IT.
"As I stepped into my role as CEO, one of my priorities was to ensure that we continue to have a strong Executive Team, committed and capable of leading us through the next phase of our growth and success,” AGC Biologics Chief Executive Officer Patricio Massera said. “Last month, I shared that Kasper Møller would expand his role to oversee both Copenhagen and Heidelberg sites, Global Supply Chain Management and Global IT. In his new role as Chief Technical Officer, Kasper will expand his scope even further to oversee all of our sites, Bothell (Seattle), Berkeley, Copenhagen, Heidelberg and Chiba, with all Site Heads/ General Managers across the regions reporting directly to him."